Reasons for Hospitalization Among Australians With Type 1 or Type 2 Diabetes and COVID-19
Copyright © 2023 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved..
OBJECTIVE: Our aim in this study was to determine the reasons for hospitalization in Australian people with diabetes who contract COVID-19.
METHODS: All COVID-19 cases reported to the Victorian Department of Health and linked hospitalization data were assessed. We determined reasons for acute (0 to 30 days) and postacute (31 to 365 days) hospitalization among those with type 1 or type 2 diabetes and COVID-19, compared to those with COVID-19 and no diabetes, and to admissions before the COVID-19 pandemic.
RESULTS: A total of 13,302 Australians with type 1 or type 2 diabetes were hospitalized in the state of Victoria in the 12 months after COVID-19 diagnosis. Respiratory diseases accounted for 40% of acute admissions among those with diabetes. Viral pneumonia was the leading cause of acute hospitalization among those with diabetes and constituted a larger proportion of admissions in those with compared to those without diabetes (adjusted prevalence ratio 1.87, 95% confidence interval 1.76 to 1.99). The distribution of postacute hospitalizations among those with diabetes aligned with that of people with diabetes before the COVID-19 pandemic.
CONCLUSIONS: Respiratory diseases are the leading cause of acute hospitalization in those with type 1 or type 2 diabetes and COVID-19. The reasons for postacute hospitalization resemble those in people with diabetes and no COVID-19. We reinforce the importance of community management of people with diabetes in the ongoing pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Canadian journal of diabetes - 48(2024), 1 vom: 15. Feb., Seite 53-58.e4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tomic, Dunya [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.02.2024 Date Revised 19.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jcjd.2023.09.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362450641 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362450641 | ||
| 003 | DE-627 | ||
| 005 | 20240219231858.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcjd.2023.09.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1299.xml |
| 035 | |a (DE-627)NLM362450641 | ||
| 035 | |a (NLM)37748685 | ||
| 035 | |a (PII)S1499-2671(23)00220-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tomic, Dunya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reasons for Hospitalization Among Australians With Type 1 or Type 2 Diabetes and COVID-19 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.02.2024 | ||
| 500 | |a Date Revised 19.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVE: Our aim in this study was to determine the reasons for hospitalization in Australian people with diabetes who contract COVID-19 | ||
| 520 | |a METHODS: All COVID-19 cases reported to the Victorian Department of Health and linked hospitalization data were assessed. We determined reasons for acute (0 to 30 days) and postacute (31 to 365 days) hospitalization among those with type 1 or type 2 diabetes and COVID-19, compared to those with COVID-19 and no diabetes, and to admissions before the COVID-19 pandemic | ||
| 520 | |a RESULTS: A total of 13,302 Australians with type 1 or type 2 diabetes were hospitalized in the state of Victoria in the 12 months after COVID-19 diagnosis. Respiratory diseases accounted for 40% of acute admissions among those with diabetes. Viral pneumonia was the leading cause of acute hospitalization among those with diabetes and constituted a larger proportion of admissions in those with compared to those without diabetes (adjusted prevalence ratio 1.87, 95% confidence interval 1.76 to 1.99). The distribution of postacute hospitalizations among those with diabetes aligned with that of people with diabetes before the COVID-19 pandemic | ||
| 520 | |a CONCLUSIONS: Respiratory diseases are the leading cause of acute hospitalization in those with type 1 or type 2 diabetes and COVID-19. The reasons for postacute hospitalization resemble those in people with diabetes and no COVID-19. We reinforce the importance of community management of people with diabetes in the ongoing pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Complications du diabète sucré | |
| 650 | 4 | |a Hospitalisation | |
| 650 | 4 | |a Maladie cardiovasculaire | |
| 650 | 4 | |a Pneumonie | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a diabetes mellitus complications | |
| 650 | 4 | |a diabetes mellitus epidemiology | |
| 650 | 4 | |a hospitalization | |
| 650 | 4 | |a pneumonia | |
| 650 | 4 | |a Épidémiologie du diabète sucré | |
| 700 | 1 | |a Shaw, Jonathan E |e verfasserin |4 aut | |
| 700 | 1 | |a Magliano, Dianna J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Canadian journal of diabetes |d 2008 |g 48(2024), 1 vom: 15. Feb., Seite 53-58.e4 |w (DE-627)NLM231201249 |x 2352-3840 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2024 |g number:1 |g day:15 |g month:02 |g pages:53-58.e4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcjd.2023.09.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2024 |e 1 |b 15 |c 02 |h 53-58.e4 | ||